[ 1 ]Hulin A, Hego A, Lancellotti P, et al. Advances in pathophysiology of calcific aortic valve disease propose novel molecular therapeutic targets[J]. Front Cardiovas Med, 2018, 5(21):21.
[ 2 ]贺钰斌, 朱丹.钙化性主动脉瓣疾病发病机制的研究进展[J].中国胸心血管外科临床杂志, 2018, 25(2):1-6.
[ 3 ]Towler DA. Molecular and cellular aspects of calcific aortic valve disease[J]. Circ Res, 2013, 113(2):198-208.
[ 4 ]高佳斌, 徐志云.主动脉瓣钙化发病机制的研究进展[J]. 国际心血管病杂志, 2016, 43(4):210-212.
[ 5 ]Gould ST, Srigunapalan S, Simmons CA, et al. Hemodynamic and cellular response feedback in calcific aortic valve disease[J]. Circ Res, 2013, 113(2):186-197.
[ 6 ]Kostyunin AE, Yuzhalin AE, Ovcharenko EA, et al. Development of calcific aortic valve disease: do we know enough for new clinical trials?[J]. J Mol Cell Cardiol, 2019, 132:189-209.
[ 7 ]Rattazzi M, Pauletto P. Valvular endothelial cells: guardians or destroyers of aortic valve integrity?[J]. Atherosclerosis, 2015, 242(2):396-398.
[ 8 ]Dahal S, Huang P, Murray BT, et al. Endothelial to mesenchymal transformation is induced by altered extracellular matrix in aortic valve endothelial cells[J]. J Biomed Mater Res A, 2017, 105(10):2729-2741.
[ 9 ]Bosse K, Hans CP, Zhao N, et al. Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease[J]. J Mol Cell Cardiol, 2013, 60:27-35.
[10]Huk DJ, Austin BF, Horne TE, et al. Valve endothelial cell-derived Tgfβ1 signaling promotes nuclear localization of Sox9 in interstitial cells associated with attenuated calcification[J]. Arterioscler Thromb Vasc Biol, 2016, 36(2):328-338.
[11]Katwa LC, Ratajska A, Cleutjens JP, et al. Angiotensin converting enzyme and kininase-Ⅱ-like activities in cultured valvular interstitial cells of the rat heart[J]. Cardiovasc Res, 1995, 29(1):57-64.
[12]Tao G, Kotick JD, Lincoln J. Heart valve development, maintenance, and disease: the role of endothelial cells[J]. Curr Top Dev Biol, 2012, 100:203-232.
[13]Gould ST, Srigunapalan S, Simmons CA, et al. Hemodynamic and cellular response feedback in calcific aortic valve disease[J]. Circ Res, 2013, 113(2):186-197.
[14]Sucosky P, Balachandran K, Elhammali A, et al. Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway[J]. Arterioscler Thromb Vasc Biol, 2009, 29(2):254-260.
[15]Paruchuri S, Yang JH, Aikawa E, et al. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2[J]. Circ Res, 2006, 99(8):861-869.
[16]Dal-Bianco JP, Aikawa E, Bischoff J, et al. Active adaptation of the tethered mitral valve insights into a compensatory mechanism for functional mitral regurgitation[J]. Circulation, 2009, 120(4):334.
[17]Kennedy JA, Hua X, Mishra K, et al. Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donors[J]. Eur J Pharmacol, 2009, 602(1):28-35.
[18]Yip CY, Blaser MC, Mirzaei Z, et al. Inhibition of pathological differentiation of valvular interstitial cells by C-type natriuretic peptide[J]. Arterioscler Thromb Vasc Biol, 2011, 31(8):1881-1889.